Clinical Trials

Showing trials with last updates posted in 2024.

NCT03590054 | COMPLETED | PHASE1
35 participants

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2024-03-22
Start Date:
2018-08-20
Completion:
2023-11-30
Conditions
  • Stage III Cutaneous Melanoma
  • Stage IV Cutaneous Melanoma
  • Locally Advanced Melanoma
  • Locally Advanced Solid Neoplasm
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Melanoma
  • Metastatic Urothelial Carcinoma
  • Non-Small Cell Lung Carcinoma
  • Stage IB Lung Cancer AJCC v7
  • Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
  • Stage III Lung Cancer AJCC v8
  • Stage III Ureter Cancer AJCC v8
  • Stage IIIA Lung Cancer AJCC v8
  • Stage IIIB Lung Cancer AJCC v8
  • Stage IIIC Lung Cancer AJCC v8
  • Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
  • Stage IV Lung Cancer AJCC v8
  • Stage IV Ureter Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT03010982 | COMPLETED | PHASE1
3 participants

Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2024-03-22
Start Date:
2018-06-20
Completion:
2019-01-08
Conditions
  • Diffuse Large B Cell Lymphoma
  • Primary Mediastinal Lymphoma
  • Mantle-Cell Lymphoma
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Advanced Solid Tumors
Interventions
  • DRUG
No Results Yet
NCT02606578 | TERMINATED
200 participants

Achalasia Patient Reported Outcomes

Study Type:
OBSERVATIONAL
Last Updated:
2024-03-22
Start Date:
2015-10-31
Completion:
2021-01-15
Conditions
  • Esophageal Achalasia
  • Achalasia
  • Achalasia, Esophageal
Interventions
  • OTHER
No Results Yet
NCT02135874 | COMPLETED | PHASE2
16 participants

Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2024-03-22
Start Date:
2014-10-27
Completion:
2023-02-21
Conditions
  • Acute Bilineal Leukemia
  • Acute Biphenotypic Leukemia
  • Acute Leukemia of Ambiguous Lineage
  • Acute Undifferentiated Leukemia
  • Mixed Phenotype Acute Leukemia
  • Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified
  • Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified
  • Recurrent Mixed Phenotype Acute Leukemia
Interventions
  • DRUG
  • BIOLOGICAL
NCT00059423 | COMPLETED
178 participants

Natural History Study for BEN

Study Type:
OBSERVATIONAL
Last Updated:
2024-03-22
Start Date:
2003-06-03
Completion:
2019-04-23
Conditions
  • Neutropenia
  • Agranulocytosis
  • Hematologic Diseases
  • Leukocyte Disorders
  • Leukopenia
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page